Document is current
Any future updates will be listed below
-
Authors
Carlos-Rivera, Fernando
Guzmán-Caniupan, Jorge Antonio
Camacho-Cordero, Luis Miguel
Aubry de Maraumont, Therese
Soria-Suárez, Noe
-
Funding
Funding for this research was provided by:
Amgen Mexico
UCB Pharma
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 18 October 2024
First Online: 7 November 2024
Declarations
:
: The manuscript does not contain clinical studies or patient data.
: FCR has partial time employment with AHS Health Consulting S.A.S. de C.V., which received funding from Amgen Mexico to conduct the study. JAGC has full time employment with and owner of AHS Health Consulting S.A.S. de C.V., which received funding from Amgen Mexico to conduct the study. LMCC is an employee of Amgen Mexico and owns stock in Company. TAdM is an employee of Amgen Mexico and owns stock in Company. NSS is an employee of Amgen Mexico and owns stock in Company.
